Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, <i>post-hoc</i> analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions.
Authors
- Yanling Zhou (ORCID: https://orcid.org/0009-0003-3484-3735)
- Xiaofeng Lan (ORCID: https://orcid.org/0000-0002-7042-084X)
- Jian-Qiang Tan
- Yuping Ning (ORCID: https://orcid.org/0000-0002-5727-2782)
- Li-Mei Gu
- Chengyu Wang (ORCID: https://orcid.org/0000-0002-5602-797X)
- Wei Zheng (ORCID: https://orcid.org/0000-0003-2371-4789)
Institutions
- Jiangmen Central Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-02-18
- DOI
- https://doi.org/10.3389/fpsyt.2025.1498952
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China